Department of Surgery, Division of Surgical Oncology, Baylor Scott & White Health, Texas A&M University Health Science Center School of Medicine, Temple, TX.
Texas A&M University Health Science Center School of Medicine, College Station, TX.
J Am Coll Surg. 2019 Jul;229(1):116-124. doi: 10.1016/j.jamcollsurg.2019.03.012. Epub 2019 Mar 28.
Patients with primary aldosteronism undergo imaging of the adrenal glands after confirmation of the disease. Adrenal venous sampling (AVS) is a useful adjunct to imaging, and advocates believe that AVS should be performed before surgical management. Others argue that patients with unilateral lesions on imaging do not require AVS. Although AVS accuracy has been established, few studies have evaluated how AVS alters management. Our study aimed to determine how AVS affected management of these patients.
Patient data were collected retrospectively from the electronic medical records at a single institution. Patients aged 18 years or older who underwent AVS with successful adrenal vein cannulation from 2007 to 2016 were included. The laterality of AVS was compared with laterality of preprocedural imaging for each patient. The management plan before AVS was determined by laterality on preprocedural imaging. The primary outcomes were management of primary aldosteronism, change in management compared with the plan before AVS, and antihypertensive medication use after therapy.
Seventy-four patients had successful adrenal venous cannulation. Thirty-three (44.6%) patients had AVS lateralization that was concordant with preprocedural imaging. Forty-one (55.4%) patients had AVS lateralization that was non-concordant with preprocedural imaging. There was a change in management in 29 (39.2%) patients.
Adrenal venous sampling can delineate the source of aldosterone hypersecretion, and often this is not concordant with cross-sectional imaging. We found that many patients avoided a potentially non-curative operation due to AVS. Adrenal venous sampling frequently alters the management of aldosteronomas and should be highly considered in patients before surgical intervention.
原发性醛固酮增多症患者在确诊后需要对肾上腺进行影像学检查。肾上腺静脉采样(AVS)是影像学检查的有用辅助手段,支持者认为在进行手术治疗之前应进行 AVS。另一些人则认为,影像学上单侧病变的患者不需要进行 AVS。尽管 AVS 的准确性已得到证实,但很少有研究评估 AVS 如何改变管理方案。我们的研究旨在确定 AVS 如何影响这些患者的管理。
患者数据从单一机构的电子病历中回顾性收集。纳入 2007 年至 2016 年期间接受 AVS 且成功进行肾上腺静脉穿刺的年龄在 18 岁或以上的患者。比较每位患者 AVS 的侧别与术前影像学的侧别。AVS 前的管理方案由术前影像学的侧别决定。主要结局是原发性醛固酮增多症的管理、与 AVS 前计划相比的管理变化以及治疗后抗高血压药物的使用。
74 例患者成功进行了肾上腺静脉穿刺。33 例(44.6%)患者的 AVS 侧别与术前影像学一致。41 例(55.4%)患者的 AVS 侧别与术前影像学不一致。29 例(39.2%)患者的治疗方案发生了变化。
肾上腺静脉采样可以描绘醛固酮分泌过多的来源,而这种情况通常与横断面成像不一致。我们发现,许多患者由于 AVS 而避免了潜在的非治愈性手术。AVS 常改变醛固酮瘤的治疗方案,在患者接受手术干预前应高度考虑。